Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Instead of three standard meals, aim for 46 smaller portions throughout the day, focusing on protein-rich foods that trigger less stomach distension
Last reviewed: April 21, 2026 Updated with Phase 3 TRIUMPH-4 data Primary sources: NEJM, Eli Lilly, ClinicalTrials.gov Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) currently in Phase 3 trials, showing stronger early weight loss data
Travel considerations that affect vial life Traveling with tirzepatide introduces unique vial longevity challenges
BPC-157 and TB-500 are prohibited substances, and their use can result in sanctions for athletes subject to testing
Research consistently shows that high-protein meals produce significantly greater GLP-1 responses than high-carbohydrate or high-fat meals
Thornicroft, G
